In this study, we found that the CTLA4, CD68, and CD4 genes were closely related to THC and CMS1 CRC; therefore, this suggested that CHCs and THCs may act as a new marker of immunotherapies in tumor treatments in the future. The gene discussed is CD68; the disease is colorectal carcinoma.